anti-her2 therapy for breast cancer ana lilia castruita-avila, m.d.
Published 5 years ago • 443 plays • Length 12:40Download video MP4
Download video MP3
Similar videos
-
0:49
dr. tolaney on the current treatment landscape for her2 breast cancer
-
1:03
is there any alternative treatment for breast cancer? - dr. nanda rajaneesh
-
0:45
dr. hamilton on using pcr to classify risk in her2 breast cancer
-
0:39
2. getting active after breast cancer treatment
-
0:44
fda approves nerlynx (neratinib) for a type of breast cancer treatment
-
2:03
dr. lori goldstein on neoadjuvant treatment for her2 breast cancer
-
2:15
dr. hurvitz on neoadjuvant therapy for her2 breast cancer
-
3:08
case 2: er breast cancer
-
5:06
factors in deciding treatment for hr breast cancer
-
1:26
dr. burstein on adjuvant endocrine therapy for er breast cancer
-
24:33
20221005 talk with a doc - breast cancer
-
2:33
challenges with neoadjuvant endocrine therapy in breast cancer
-
3:12
combination treatments for premenopausal breast cancer: endocrine therapy and ovarian suppression
-
5:01
neoadjuvant lapatinib in her2 early breast cancer
-
51:56
new & supporting data for optimizing therapy in her2 breast cancer | dr. kaklamani and dr. o’regan
-
2:51
breast cancer: extended adjuvant therapy and cost factors
-
7:11
case 1: adjuvant therapy for residual disease in her2 breast cancer
-
1:27
treating er breast cancer patients with endocrine therapy resistance
-
4:56
neoadjuvant talazoparib active in brca-mutated early breast cancer | jennifer litton